Search company, investor...

Worg Pharmaceuticals

cn.worgpharma.com

Founded Year

2018

Stage

Series B | Alive

Total Raised

$88.33M

Last Raised

$57.46M | 3 mos ago

About Worg Pharmaceuticals

Worg Pharmaceuticals is committed to the development and commercialization of innovative drugs. Based on its technology platform, the company focuses on diagnosing allergens and allergen-specific immunotherapy, creating a closed-loop allergy diagnosis and treatment platform with complete management. The company was founded in 2018 and is based in Hangzhou, China.

Headquarters Location

Room 706, Building 6, Haiju Center, No. 501, No. 2 Street, Qiantang New District

Hangzhou, Zhejiang ,

China

+86-571-85065375

Missing: Worg Pharmaceuticals's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Worg Pharmaceuticals's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Worg Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Worg Pharmaceuticals is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Worg Pharmaceuticals Patents

Worg Pharmaceuticals has filed 1 patent.

The 3 most popular patent topics include:

  • Immune system
  • Immunology
  • Acetylcholinesterase inhibitors
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/17/2019

Allergology, Food allergies, Acetylcholinesterase inhibitors, Immune system, Immunology

Application

Application Date

5/17/2019

Grant Date

Title

Related Topics

Allergology, Food allergies, Acetylcholinesterase inhibitors, Immune system, Immunology

Status

Application

Latest Worg Pharmaceuticals News

China’s Worg Pharmaceuticals Raises ~USD58m Series B Led by Junson Capital, Lapam Capital, Kaitai Capital, Puhua Capital and Anji Ruixing Capital

Sep 20, 2022

INDUSTRY NEWS China’s Worg Pharmaceuticals Raises ~USD58m Series B Led by Junson Capital, Lapam Capital, Kaitai Capital, Puhua Capital and Anji Ruixing Capital September 14, 2022 Source(s): ChinaVenture Worg Pharmaceuticals, a China-based biopharmaceutical company developing allergy and autoimmune treatments, raised a CNY400m (~USD58m) Series B led by Junson Capital, Lapam Capital, Kaitai Capital, Puhua Capital and Anji Ruixing Capital. Read more Sign up

Worg Pharmaceuticals Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Worg Pharmaceuticals Rank

Worg Pharmaceuticals Frequently Asked Questions (FAQ)

  • When was Worg Pharmaceuticals founded?

    Worg Pharmaceuticals was founded in 2018.

  • Where is Worg Pharmaceuticals's headquarters?

    Worg Pharmaceuticals's headquarters is located at Room 706, Building 6, Haiju Center, No. 501, No. 2 Street, Qiantang New District, Hangzhou.

  • What is Worg Pharmaceuticals's latest funding round?

    Worg Pharmaceuticals's latest funding round is Series B.

  • How much did Worg Pharmaceuticals raise?

    Worg Pharmaceuticals raised a total of $88.33M.

  • Who are the investors of Worg Pharmaceuticals?

    Investors of Worg Pharmaceuticals include Puhua Capital, Kaitai Capital, Junson Capital, Lapam Capital and Anji Ruixing Capital.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.